CNBC - The biggest loser among the 30 Dow components Wednesday was Merck & Co., which late Tuesday reported a $1.63 billion fourth-quarter loss in the fourth quarter due mostly to charges for its Vioxx litigation settlement. Merck fell $2.32, or nearly 4.8 Read More
Forbes - saw its […]
Archive for January, 2008
Stocks slip as investors await Fed (Vioxx News)
Thursday, January 31st, 2008Posted in Vioxx | No Comments »
DJIA Leaders & Laggards: AIG BA - Forbes (Vioxx News)
Thursday, January 31st, 2008Aljazeera.net
DJIA Leaders & Laggards: AIG BAForbes, NY - Jan 30, 2008Merck & Co. lost $1.32, or 2.8 percent, to $46.69 after a Vioxx litigation settlement charge caused the drug maker to post a fourth-quarter loss. …Stocks' Advance After Rate Cut Is Short-Lived Washington Postall 112 news articles
Read More…
Conde Nast Portfolio
Merck Posts Loss on Vioxx Lawsuits; Roche […]
Posted in Vioxx | No Comments »
Name similarities lead to medication mix-ups - DetNews.com (Vioxx News)
Thursday, January 31st, 2008Name similarities lead to medication mix-upsDetNews.com, MI - 6 hours agoFrom Prilosec to Prozac, Vioxx to Zyvox, the report fingers 1470 drugs implicated in 26000 medication errors in 2006 due to drugs having brand and/or …
Read More…
Aljazeera.net
DJIA Leaders & Laggards: AIG BAForbes, NY - 14 hours agoMerck & Co. lost $1.32, or 2.8 percent, to $46.69 after a […]
Posted in Vioxx | No Comments »
Stock markets tepid ahead of Fed interest rate decision (Vioxx News)
Thursday, January 31st, 2008Detroit News - Inc. took a fourth-quarter loss due to special charges, including a settlement costs for withdrawing Vioxx, a drug for arthritis. But its earnings excluding special costs beat estimates of Thomson Financial analysts. Overseas markets fell ahead of Read More
MSN UK News - Merck & Co. on Tuesday posted […]
Posted in Vioxx | No Comments »
Merck Swings to Loss on Vioxx Charges, Shares Fall (Vioxx News)
Wednesday, January 30th, 2008CNBC - Merck on Wednesday reported a fourth-quarter loss due to charges from a costly settlement related to its withdrawn Vioxx arthritis drug, but results soundly beat Wall Street forecasts and lifted its shares 2 percent. [ MRK Loading Read More
Reuters - fell 4.6 percent to $45.79 […]
Posted in Vioxx | No Comments »
Merck Posts Loss on Vioxx Lawsuits; Roche Gains on Cancer Drugs (Vioxx News)
Wednesday, January 30th, 2008Bloomberg - Jan. 30 (Bloomberg) — Merck & Co. reported a loss after booking $4.85 billion in costs to settle Vioxx lawsuits, while Roche Holding AG boosted profit on sales of cancer medicines. Both drugmakers beat analysts’ estimates. Merck, the third-largest U Read More
Street.Com - On a GAAP basis, the company […]
Posted in Vioxx | No Comments »
An Economic Shot In The Arm (Vioxx News)
Tuesday, January 29th, 2008Daily News-Record - Merck’s Stonewall plant had 900 employees in 2004, when arthritis drug Vioxx was pulled from the market and sales declined. But the company has recovered, reporting third-quarter-2007 sales of $6.1 billion, up 12 percent from the same period in 2006. Read More
World Socialist Web Site - The conduct […]
Posted in Vioxx | No Comments »
Clemens tale hard to believe (Vioxx News)
Monday, January 28th, 2008Boston Globe - He also said he gulped anti-inflammatory Vioxx pills “like it was Skittles.” Wallace let Clemens get off easy regarding Andy Pettitte. Pettitte is Clemens’s former training partner and teammate. They share the same agents. Pettitte fessed up to Read More
Oakland Press - Other items that Granholm plans to […]
Posted in Vioxx | No Comments »
Trouble Brewing? - Merck, Schering-Plough Get New York Subpoena … - RTT News (Vioxx News)
Monday, January 28th, 2008Earthtimes
Trouble Brewing? - Merck, Schering-Plough Get New York Subpoena …RTT News, NY - Jan 26, 2008It's barely months Merck settled the 3-year legal battle related to its blockbuster Vioxx painkiller and the drug giant is back again mired in controversy …Reuters Health News Summary San Diego Union Tribuneall 301 news articles
Read More…
New York Times
In Vioxx […]
Posted in Vioxx | No Comments »
In Vioxx Settlement, Testing a Legal Ideal: A Lawyer’s Loyalty - New York Times (Vioxx News)
Monday, January 28th, 2008New York Times
In Vioxx Settlement, Testing a Legal Ideal: A Lawyer’s LoyaltyNew York Times, United States - Jan 22, 2008The new Maginot Line is the Vioxx settlement, and the blitz is on. The first thing to know about the settlement, announced in November, is that it intends …
Read More…
Earthtimes
Trouble Brewing? - Merck, Schering-Plough Get New York […]
Posted in Vioxx | No Comments »

